참고문헌
- Abd El-Hafez YG, Moustafa HM, Khalil HF, et al (2013). Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma. Oral Oncol, 49, 261-8. https://doi.org/10.1016/j.oraloncology.2012.09.005
- Abramyuk A, Appold S, Zophel K, et al (2012). Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non-small cell lung cancer scheduled for radiotherapy-a retrospective study. Lung Cancer, 78, 148-52. https://doi.org/10.1016/j.lungcan.2012.08.001
- Arslan N, Tuncel M, Kuzhan O, et al (2011). Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer. Ann Nucl Med, 25, 406-13. https://doi.org/10.1007/s12149-011-0478-y
- Bille A, Okiror L, Skanjeti A, et al (2013). The prognostic significance of maximum standardized uptake value of primary tumor in surgically treated non-small-cell lung cancer patients: analysis of 413 cases. Clin Lung Cancer, 14, 149-56. https://doi.org/10.1016/j.cllc.2012.04.007
- Bulbul Y, Oztuna F, Topbas M, Ozlu T (2005). Survival analyses of patients with thoracic complications secondary to bronchial carcinoma at the time of diagnosis. Respiration, 72, 388-94. https://doi.org/10.1159/000086253
- Bulbul Y, Eris B, Orem A, et al (2010). Pulmonary atelectasis and survival in advanced non-small cell lung carcinoma. Ups J Med Sci, 115, 176-80. https://doi.org/10.3109/03009731003695624
- Chen C, Zheng H, Gao W, et al (2010). Prognosis and staging of superficial endobronchial lung cancer: the impact of invasion depth, tumor diameter, and coexistent pneumonitis or atelectasis. Chin Med J, 123, 1505-9.
-
Cheng NM, Chang JT, Huang CG, et al (2012). Prognostic value of pretreatment
$^{18}F$ -FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging, 39, 1673-84. https://doi.org/10.1007/s00259-012-2186-9 - Cho A, Hur J, Kang WJ, et al (2011). Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction. Eur Radiol, 21, 1077-87. https://doi.org/10.1007/s00330-010-2006-1
- Dediu M, Crisan E, Radut M, et al (2009). The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study. Lung Cancer, 63, 271-6. https://doi.org/10.1016/j.lungcan.2008.05.007
- De Leyn P, Lardinois D, Van Schil PE, et al (2007). ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothor Surg, 32, 1-8. https://doi.org/10.1016/j.ejcts.2007.01.075
-
Ding XP, Zhang J, Li BS, et al (2012). Feasibility of shrinking field radiation therapy through
$^{18}F$ -FDG PET/CT after 40 Gy for stage III non-small cell lung cancers. Asian Pac J Cancer Prev, 13, 319-23. https://doi.org/10.7314/APJCP.2012.13.1.319 - Gerbaudo VH, Julius B (2007). Anatomo-metabolic characteristics of atelectasis in F-18 FDG-PET/CT imaging. Eur J Radiol, 64, 401-5. https://doi.org/10.1016/j.ejrad.2007.08.013
- Lee P, Weerasuriva DK, Lavori PW, et al (2007). Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys, 69, 328-33. https://doi.org/10.1016/j.ijrobp.2007.04.036
- Liao S, Penney BC, Zhang H, et al (2012). Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in stage IV nonsurgical small-cell lung cancer. Acad Radiol, 19, 69-77. https://doi.org/10.1016/j.acra.2011.08.020
- Liu FY, Chao A, Lai CH, et al (2012). Metabolic tumor volume by 18F-FDG PET/CT is prognostic for stage IVB endometrial carcinoma. Gynecol Oncol, 125, 566-71. https://doi.org/10.1016/j.ygyno.2012.03.021
- Moon SH, Choi JY, Lee HJ, et al (2013). Prognostic value of 18F- FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters. Head Neck, 35, 15-22. https://doi.org/10.1002/hed.22904
- Mutlu H, Buyukcelik A, Erden A, et al (2013). Staging with PET-CT in patients with locally advanced non small cell lung cancer is superior to conventional staging methods in terms of survival. Asian Pac J Cancer Prev, 14, 3743-6. https://doi.org/10.7314/APJCP.2013.14.6.3743
- Obara P, Pu Y (2013). Prognostic value of metabolic tumor burden in lung cancer. Chin J Cancer Res, 25, 615-22.
- Ou SH, Zell JA, Ziogas A, Anton-Culver H (2008). Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size. Chest, 133, 662-9. https://doi.org/10.1378/chest.07-1306
- Pauwels EK, Coumou AW, Kostkiewicz M, Kairemo K (2013). [F]Fluro-2-Deoxy-D-Glucose positron emission tomography/computed tomography imaging in oncology: initial staging and evaluation of cancer therapy. Med Princ Pract, 22, 427-37. https://doi.org/10.1159/000346303
- Roedl JB, Colen RR, Holalkere NS, et al (2008). Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation. Radiother Oncol, 89, 278-86. https://doi.org/10.1016/j.radonc.2008.06.014
- Sahin F, Yildiz P (2011). Radiological, bronchoscopic and histopathologic characteristics of patients with primary lung cancer in Turkey (2006-2009). Asian Pac J Cancer Prev, 12, 1947-52.
- Shyn PB (2013). Interventional positron emission tomography/computed tomography: state-of-the-art. Tech Vasc Interv Radiol, 6, 182-90.
- Yin LJ, Yu XB, Ren YG, et al (2013). Utilization of PET-CT in target volume delineation for three-dimensional conformal radiotherapy in patients with non-small cell lung cancer and atelectasis. Multidiscip Respir Med, 8, 21. https://doi.org/10.1186/2049-6958-8-21
- Zaizen Y, Azuma K, Kurata S, et al (2012). Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy. Eur J Radiol, 81, 4179-84. https://doi.org/10.1016/j.ejrad.2012.07.009
- Zhang H, Wroblewski K, Appelbaum D, Pu Y (2013). Independent Prognostic Value of Whole-body Metabolic Tumor Burden from FDG-PET in Non-Small Cell Lung Cancer. Int J Comput Assist Radiol Surg, 8, 181-91.
- Zhu SH, Zhang Y, Yu YH, et al (2013). FDG PET-CT in non-small cell lung cancer: relationship between primary tumor FDG uptake and extensional or metastatic potential. Asian Pac J Cancer Prev, 14, 2925-9. https://doi.org/10.7314/APJCP.2013.14.5.2925
피인용 문헌
- Differences in the Prognostic Significance of the SUVmax between Patients with Resected Pulmonary Adenocarcinoma and Squamous Cell Carcinoma vol.15, pp.23, 2014, https://doi.org/10.7314/APJCP.2014.15.23.10171
- Comparison of Metabolic and Anatomic Response to Chemotherapy Based on PERCIST and RECIST in Patients with Advanced Stage Non-small Cell Lung Cancer vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.321
- Importance of PET/CT Scan Use in Planning Radiation Therapy for Lymphoma vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.2051